[1]
Congenital anomalies fact sheet updated September 2016 http://www.who.int/mediacentre/factsheets/fs370/en/ (Accessed December 2017).
[2]
Metabolic disorders: MedlinePlus".
www.nlm.nih.gov
Retrieved 27 July 2015. https://medlineplus.gov/metabolicdisorders.html (Accessed December 2017).
[3]
Inherited Metabolic Disorders Overview: Overview, Clinical Features and Differential Diagnosis, Epidemiology and Statistics. (Accessed December
2017).
[4]
Scotti, L.; Monteiro, A.F.M.; Viana, J.O.; Mendonça Jr., F.J.B.; Ishiki, H.M.; Tchouboun, E.N.; Santos, R.; Scotti, M.T. Multi-target drugs against
metabolic disorders. Endocr. Metab. Immune. Disord Drug Targets, 2019. 19(4), 402-418
[5]
Singla, R.K.; Dubey, A.K. Phytochemical profiling, gc-ms analysis and α-amylase inhibitory potential of ethanolic extract of Cocos nucifera Linn. Endocarp. Endocr. Metab. Immune Disord. Drug Targets, 2019, 19(4), 419-442.
[6]
Khan, H.; Amin, D.; Tewari, D.; Nabavi, S.M.; Atanas, A.G. Plant derived glycosides with α-glucosidase inhibitory activity: Current standing and future prospects. Endocr. Metab. Immune Disord. Drug Targets, 2019, 19(4), 391-401.
Related Journals
Current Diabetes Reviews
Current Medicinal Chemistry
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
Related Books
Mitochondrial DNA and the Immuno-inflammatory Response: New Frontiers to Control Specific Microbial Diseases
Pharmacological and Molecular Perspectives on Diabetes
Frontiers in Clinical Drug Research – Anti Allergy Agents
Frontiers in Clinical Drug Research-Diabetes and Obesity
Frontiers in Inflammation
Frontiers in Clinical Drug Research-Diabetes and Obesity
Article Metrics
26
3